PFE Pfizer Inc

Price (delayed)

$41.68

Market cap

$233.31B

P/E Ratio

20.94

Dividend/share

$1.54

EPS

$1.99

Enterprise value

$271.24B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
The quick ratio has grown by 47% YoY and by 13% from the previous quarter
PFE's debt is down by 24% YoY
Pfizer's net income has decreased by 30% YoY but it has increased by 15% QoQ
Pfizer's EPS has decreased by 30% YoY but it has increased by 15% from the previous quarter
The price to earnings (P/E) is 13% higher than the 5-year quarterly average of 18.5 and 11% higher than the last 4 quarters average of 18.8
The gross margin has contracted by 4.3% YoY and by 3.8% from the previous quarter

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.6B
Market cap
$233.31B
Enterprise value
$271.24B
Valuations
Price to earnings (P/E)
20.94
Price to book (P/B)
3.39
Price to sales (P/S)
5.23
EV/EBIT
22.8
EV/EBITDA
16.26
EV/Sales
6.1
Earnings
Revenue
$44.46B
EBIT
$11.9B
EBITDA
$16.68B
Free cash flow
$12.96B
Per share
EPS
$1.99
Free cash flow per share
$2.32
Book value per share
$12.3
Revenue per share
$7.96
TBVPS
$14.52
Balance sheet
Total assets
$158.82B
Total liabilities
$89.95B
Debt
$39.7B
Equity
$68.62B
Working capital
$12.88B
Liquidity
Debt to equity
0.58
Current ratio
1.48
Quick ratio
0.88
Net debt/EBITDA
2.27
Margins
EBITDA margin
37.5%
Gross margin
76.3%
Net margin
24.9%
Operating margin
20.9%
Efficiency
Return on assets
6.6%
Return on equity
17%
Return on invested capital
11.6%
Return on capital employed
9%
Return on sales
26.8%
Dividend
Dividend yield
3.69%
DPS
$1.54
Payout ratio
77.4%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
0.51%
1 week
3.3%
1 month
6.73%
1 year
8.51%
YTD
13.23%
QTD
6.44%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$44.46B
Gross profit
$33.94B
Operating income
$9.3B
Net income
$11.09B
Gross margin
76.3%
Net margin
24.9%
PFE's net margin is down by 40% YoY but it is up by 9% from the previous quarter
Pfizer's net income has decreased by 30% YoY but it has increased by 15% QoQ
The operating income has grown by 24% from the previous quarter
The company's operating margin rose by 17% QoQ

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
20.94
P/B
3.39
P/S
5.23
EV/EBIT
22.8
EV/EBITDA
16.26
EV/Sales
6.1
Pfizer's EPS has decreased by 30% YoY but it has increased by 15% from the previous quarter
The price to earnings (P/E) is 13% higher than the 5-year quarterly average of 18.5 and 11% higher than the last 4 quarters average of 18.8
PFE's P/B is 13% above its last 4 quarters average of 3.0 and 2.7% above its 5-year quarterly average of 3.3
Pfizer's equity has increased by 9% QoQ and by 6% YoY
Pfizer's revenue has increased by 17% YoY and by 6% QoQ
PFE's P/S is 11% above its 5-year quarterly average of 4.7 and 4.6% above its last 4 quarters average of 5.0

Efficiency

How efficient is Pfizer business performance
Pfizer's ROS has decreased by 37% YoY but it has increased by 11% from the previous quarter
The company's return on invested capital fell by 36% YoY but it rose by 17% QoQ
The ROE fell by 32% YoY but it rose by 14% QoQ
Pfizer's ROA has decreased by 31% YoY but it has increased by 16% from the previous quarter

Dividends

What is PFE's dividend history
DPS
$1.54
Dividend yield
3.69%
Payout ratio
77.4%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 77% greater than its total liabilities
The quick ratio has grown by 47% YoY and by 13% from the previous quarter
The current ratio has grown by 44% YoY and by 10% from the previous quarter
PFE's debt is 42% less than its equity
The debt to equity has contracted by 28% YoY and by 8% from the previous quarter
PFE's debt is down by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.